Beta-benzal-butyric acid, a new anti-adhesive drug.
D000244:Adenosine Diphosphate / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000284:Administration, Oral; D000475:Alkenes / Q000494:pharmacology; D001777:Blood Coagulation / Q000187:drug effects; D001779:Blood Coagulation Factors / Q000378:metabolism; D001792:Blood Platelets / Q000378:metabolism; D002087:Butyrates / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D002449:Cell Aggregation / Q000187:drug effects; D003094:Collagen / Q000037:antagonists & inhibitors; D003720:Densitometry; D004305:Dose-Response Relationship, Drug; D004837:Epinephrine / Q000037:antagonists & inhibitors; D004912:Erythrocytes; D005342:Fibrinolysis / Q000187:drug effects; D005343:Fibrinolytic Agents / Q000494:pharmacology; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy; D066298:In Vitro Techniques; D008055:Lipids / Q000097:blood; D008259:Macroglobulins / Q000032:analysis; D010958:Plasminogen / Q000032:analysis; D010973:Platelet Adhesiveness / Q000187:drug effects*; D013917:Thrombin / Q000037:antagonists & inhibitors; D013997:Time Factors
D000475:Alkenes; D001779:Blood Coagulation Factors; D002087:Butyrates; D005343:Fibrinolytic Agents; D008055:Lipids; D008259:Macroglobulins; D000244:Adenosine Diphosphate; D010958:Plasminogen; D003094:Collagen; D013917:Thrombin; D004837:Epinephrine